Wendy Montero Pérez has a bachelor’s degree in pharmaceutical sciences from Havana University. She works in the Department of Quality Assurance at the Center of Molecular Immunology in Havana.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1
and chronic conditions such as cancer
1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061